STATELESSNESS IN PROTRACTED REFUGEE SITUATIONS: FORMER ANGOLAN AND RWANDAN REFUGEES IN ZAMBIA



Case Report: Identification of Two Rare Fusions, PDK1-ALK and STRN-ALK, That Coexist in a Lung Adenocarcinoma Patient and the Response to Alectinib

Several double ALK fusions coexisting in one patient have been reported.However, few studies have reported the clinical efficacy of ALK inhibitors in rare double ALK fusions.Here, we described SHEATHS a rare PDK1-ALK, STRN-ALK double-fusion variant in a patient with metastatic lung adenocarcinoma.The patient responded well to alectinib (600 mg) CHA

read more

Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification

Aims The Non-adherence Academic Research Consortium (NARC) has recently developed a consensus-based standardized classification for medication non-adherence in cardiovascular clinical trials.We aimed to assess the prevalence of NARC-defined self-reported non-adherence to P2Y12 inhibitors and its impact on clinical outcomes in patients undergoing pe

read more